Metallothionein III is reduced in Alzheimer's disease. (Q48955424)

17 February 2018

title

Metallothionein III is reduced in Alzheimer's disease. (English)

1 reference

17 February 2018

0 references

Yu WH

1

1 reference

17 February 2018

Lukiw WJ

2

1 reference

17 February 2018

Bergeron C

3

1 reference

17 February 2018

Niznik HB

4

1 reference

17 February 2018

Fraser PE

5

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 March 2001

1 reference

17 February 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

17 February 2018

volume

894

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

37-45

1 reference

17 February 2018

Expression of growth inhibitory factor (GIF) in normal and injured rat brains

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Metallothioneins in brain--the role in physiology and pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Changes of growth inhibitory factor after stab wounds in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Alzheimer's disease, beta-amyloid protein and zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

MT-III, a brain-specific member of the metallothionein gene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

The N-terminal portion of growth inhibitory factor is sufficient for biological activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

Chemical modulation of metallothionein I and III mRNA in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903196-6

10.1016/S0006-8993(00)03196-6

7 January 2021

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11245813

1 reference

17 February 2018